Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Dealnews2025-11-08T12:38:25+00:00November 8th, 2025|The New York Times|
Novo Nordisk’s Woes Are Slimming Denmark’s Economic Growthnews2025-09-22T04:01:17+00:00September 22nd, 2025|The New York Times|
Where U.S. Medicines Are Made and How Trump’s Tariffs Could Affect Themnews2025-08-24T03:39:58+00:00August 24th, 2025|The New York Times|
Is Obesity a Disease? It’s Complicated in the Age of Ozempic.news2024-09-19T10:55:46+00:00September 19th, 2024|The New York Times|
How Ozempic Is Transforming a Small Danish Townnews2024-04-20T04:01:50+00:00April 20th, 2024|The New York Times|
Inside Novo Nordisk, the Company Behind Ozempic and Wegovynews2024-04-20T04:01:23+00:00April 20th, 2024|The New York Times|
Ozempic and Wegovy, Novo Nordisk’s Weight Loss Drugs, Reshape Denmark’s Economynews2023-08-28T22:32:35+00:00August 28th, 2023|The New York Times|
Headache Research Advances Though Cures Are Elusivenews2021-07-23T09:00:14+00:00July 23rd, 2021|The New York Times|
